People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Celularity Inc. | — | Biotechnology | Series C | $117.7M | $3.2B | 2018 |
| Scilex Holding Co | — | Biotechnology | Series D+ | $104.6M | $19.5M | 2023 |
| Zelos Therapeutics Inc | — | Pharmaceuticals | Series A | $17.8M | $75.0M | 2010 |
Jaisim Shah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jaisim Shah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Henry Ji | 2 | 5 |
| PETER DIAMANDIS | 1 | 10 |
| Joseph Zakrzewski | 1 | 6 |
| John Sculley | 1 | 6 |
| Timothy Smith | 1 | 5 |
| Farah Champsi | 1 | 5 |
| Colin Goddard | 1 | 5 |
| Robert Hariri | 1 | 5 |
| Brian MacDonald | 1 | 4 |
| CARLOS RAMIREZ | 1 | 4 |
| Andrew Pecora | 1 | 4 |
| Tim Smith | 1 | 4 |
| Donald Hayden | 1 | 3 |
| Alex Barkas | 1 | 3 |
| Andrew Von Eschenbach | 1 | 3 |
| David Krause | 1 | 3 |
| Jeff Courtney | 1 | 3 |
| Cynthia Lavoie | 1 | 2 |
| Yue Alexander Wu | 1 | 2 |
| Peter R. Diamandis | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.